著者
竹島 多賀夫
出版者
日本神経治療学会
雑誌
神経治療学 (ISSN:09168443)
巻号頁・発行日
vol.35, no.3, pp.307-312, 2018 (Released:2018-12-25)
参考文献数
27

Neuromodulation is focused as a new therapy for primary headache disorders.Non–invasive neuromodulation devices are free from surgical risks and those costs are practical ranges in primary care settings. It is also important most of these devices are self–applicable after the appropriate introductions.Transcutaneous supraorbital trigeminal neurostimulation (Cefaly) is widely used in Europe and United States, and clinical evidence for migraine management have been accumulated. I demonstrated our preliminary favorable results of Cefaly devices for Japanese migraine sufferers. Non–invasive vagus nerve stimulation (nVNS) has been approved in United States. Single–pulse transcranial magnetic stimulation (sTMS) is also expected to be a new device for chronic pain including migraine headache.These non–invasive neuromodulation devices will open new avenues on the management of primary headaches including migraine.

言及状況

外部データベース (DOI)

Twitter (2 users, 2 posts, 2 favorites)

@nanriyuta https://t.co/SmMBjfgwPp ご検討ください
55/100 『非侵襲的神経刺激療法』 ・リスク、コスト ↓ ・自身で実施可 ・Fig.1 ✅Cefaly ・三叉神経第1枝分枝への電気刺激 ・片頭痛予防薬同等(Fig.2) ・妊娠中やペースメーカー同時使用可 ✅nVNS ・低閾値有髄A線維を刺激 ・Fig.3 ・慢性群発頭痛への効果も検討 https://t.co/tE6vIzPdZD https://t.co/JkB9WWFTsY

収集済み URL リスト